172 related articles for article (PubMed ID: 1479579)
1. 2-(aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents.
Capps DB; Dunbar J; Kesten SR; Shillis J; Werbel LM; Plowman J; Ward DL
J Med Chem; 1992 Dec; 35(26):4770-8. PubMed ID: 1479579
[TBL] [Abstract][Full Text] [Related]
2. Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias.
Cholody WM; Martelli S; Konopa J
J Med Chem; 1992 Jan; 35(2):378-82. PubMed ID: 1732555
[TBL] [Abstract][Full Text] [Related]
3. Potential antitumor agents. 38. 3-substituted 5-carboxamido derivatives of amsacrine.
Denny WA; Atwell GJ; Baguley BC
J Med Chem; 1983 Nov; 26(11):1619-25. PubMed ID: 6688829
[TBL] [Abstract][Full Text] [Related]
4. Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines.
Horwitz JP; Massova I; Wiese TE; Wozniak AJ; Corbett TH; Sebolt-Leopold JS; Capps DB; Leopold WR
J Med Chem; 1993 Nov; 36(23):3511-6. PubMed ID: 8280289
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship for antineoplastic imidazoacridinones: synthesis and antileukemic activity in vivo.
Cholody WM; Horowska B; Paradziej-Lukowicz J; Martelli S; Konopa J
J Med Chem; 1996 Mar; 39(5):1028-32. PubMed ID: 8676337
[TBL] [Abstract][Full Text] [Related]
6. 6H-pyrazolo[4,5,1-de]acridin-6-ones as a novel class of antitumor agents. Synthesis and biological activity.
Sugaya T; Mimura Y; Shida Y; Osawa Y; Matsukuma I; Ikeda S; Akinaga S; Morimoto M; Ashizawa T; Okabe M
J Med Chem; 1994 Apr; 37(7):1028-32. PubMed ID: 8151613
[TBL] [Abstract][Full Text] [Related]
7. Potential antitumor agents. 42. Structure-activity relationships for acridine-substituted dimethyl phosphoramidate derivatives of 9-anilinoacridine.
Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1984 Aug; 27(8):1053-6. PubMed ID: 6747989
[TBL] [Abstract][Full Text] [Related]
8. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
[TBL] [Abstract][Full Text] [Related]
9. Rational design, synthesis and biological evaluation of thiadiazinoacridines: a new class of antitumor agents.
Antonini I; Polucci P; Magnano A; Cacciamani D; Konieczny MT; Paradziej-Łukowicz J; Martelli S
Bioorg Med Chem; 2003 Feb; 11(3):399-405. PubMed ID: 12517435
[TBL] [Abstract][Full Text] [Related]
10. Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
Showalter HD; Johnson JL; Hoftiezer JM; Turner WR; Werbel LM; Leopold WR; Shillis JL; Jackson RC; Elslager EF
J Med Chem; 1987 Jan; 30(1):121-31. PubMed ID: 3806589
[TBL] [Abstract][Full Text] [Related]
11. Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemias.
Showalter HD; Angelo MM; Berman EM; Kanter GD; Ortwine DF; Ross-Kesten SG; Sercel AD; Turner WR; Werbel LM; Worth DF
J Med Chem; 1988 Aug; 31(8):1527-39. PubMed ID: 3397990
[TBL] [Abstract][Full Text] [Related]
12. Activity of the pyrazoloacridines against multidrug-resistant tumor cells.
Sebolt J; Havlick M; Hamelehle K; Nelson J; Leopold W; Jackson R
Cancer Chemother Pharmacol; 1989; 24(4):219-24. PubMed ID: 2752501
[TBL] [Abstract][Full Text] [Related]
13. 5-[(Aminoalkyl)amino]imidazo[4,5,1-de]acridin-6-ones as a novel class of antineoplastic agents. Synthesis and biological activity.
Cholody WM; Martelli S; Paradziej-Lukowicz J; Konopa J
J Med Chem; 1990 Jan; 33(1):49-52. PubMed ID: 2296035
[TBL] [Abstract][Full Text] [Related]
14. Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.
Antonini I; Polucci P; Cola D; Bontemps-Gracz M; Pescalli N; Menta E; Martelli S
Anticancer Drug Des; 1996 Jun; 11(4):339-49. PubMed ID: 8679056
[TBL] [Abstract][Full Text] [Related]
15. Pyrimidoacridine derivatives as potential antitumor agents.
Antonini I; Cola D; Martelli S; Cholody WM; Konopa J
Farmaco; 1992; 47(7-8):1035-46. PubMed ID: 1445611
[TBL] [Abstract][Full Text] [Related]
16. Potential antitumor agents. 47. 3'-Methylamino analogues of amsacrine with in vivo solid tumor activity.
Atwell GJ; Baguley BC; Finlay GJ; Rewcastle GW; Denny WA
J Med Chem; 1986 Sep; 29(9):1769-76. PubMed ID: 3755758
[TBL] [Abstract][Full Text] [Related]
17. Potential antitumor agents. 43. Synthesis and biological activity of dibasic 9-aminoacridine-4-carboxamides, a new class of antitumor agent.
Atwell GJ; Cain BF; Baguley BC; Finlay GJ; Denny WA
J Med Chem; 1984 Nov; 27(11):1481-5. PubMed ID: 6492078
[TBL] [Abstract][Full Text] [Related]
18. Potential antitumor agents. 17. 9-Anilino-10-methylacridinium salts.
Cain BF; Atwell GJ; Denny WA
J Med Chem; 1976 Jun; 19(6):772-7. PubMed ID: 950644
[TBL] [Abstract][Full Text] [Related]
19. Potential antitumor agents. 12. 9-Anilinoacridines.
Atwell GJ; Cain BF; Seelye RN
J Med Chem; 1972 Jun; 15(6):611-5. PubMed ID: 5030927
[No Abstract] [Full Text] [Related]
20. Potential antitumor agents. 37. Organophosphorus derivatives of 9-anilinoacridine.
Rewcastle GW; Baguley BC; Cain BF
J Med Chem; 1982 Oct; 25(10):1231-5. PubMed ID: 7143362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
